264 related articles for article (PubMed ID: 25933967)
1. The pharmacokinetic interaction between levofloxacin and sunitinib.
Czyrski A; Kondys K; Szałek E; Karbownik A; Grześkowiak E
Pharmacol Rep; 2015 Jun; 67(3):542-4. PubMed ID: 25933967
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of sunitinib in combination with fluoroquinolones in rabbit model.
Szałek E; Karbownik A; Grabowski T; Sobańska K; Wolc A; Grześkowiak E
Pharmacol Rep; 2013; 65(5):1383-90. PubMed ID: 24399735
[TBL] [Abstract][Full Text] [Related]
3. The influence of the time-of-day administration of the drug on the pharmacokinetics of sunitinib in rabbits.
Szałek E; Karbownik A; Sobańska K; Połom W; Grabowski T; Wolc A; Matuszewski M; Grześkowiak E
Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2393-9. PubMed ID: 25219843
[TBL] [Abstract][Full Text] [Related]
4. Sunitinib in combination with clarithromycin or azithromycin - is there a risk of interaction or not?
Szałek E; Karbownik A; Połom W; Matuszewski M; Sobańska K; Urjasz H; Grabowski T; Wolc A; Grześkowiak E
Pharmacol Rep; 2012; 64(6):1554-9. PubMed ID: 23406766
[TBL] [Abstract][Full Text] [Related]
5. Relationship Between Sunitinib Pharmacokinetics and Administration Time: Preclinical and Clinical Evidence.
Kloth JS; Binkhorst L; de Wit AS; de Bruijn P; Hamberg P; Lam MH; Burger H; Chaves I; Wiemer EA; van der Horst GT; Mathijssen RH
Clin Pharmacokinet; 2015 Aug; 54(8):851-8. PubMed ID: 25647628
[TBL] [Abstract][Full Text] [Related]
6. Drug interaction between sunitinib and cimetidine and contribution of the efflux transporter ATP-binding cassette C2 to biliary excretion of sunitinib in rats.
Arakawa-Todo M; Ueyama J; Nomura H; Abe F; Tsukiyama I; Matsuura K; Hasegawa T
Anticancer Res; 2013 Aug; 33(8):3105-11. PubMed ID: 23898066
[TBL] [Abstract][Full Text] [Related]
7. Diclofenac sex-divergent drug-drug interaction with Sunitinib: pharmacokinetics and tissue distribution in male and female mice.
Chew CC; Ng S; Chee YL; Koo TW; Liew MH; Chee EL; Modamio P; Fernández C; Mariño EL; Segarra I
Invest New Drugs; 2017 Aug; 35(4):399-411. PubMed ID: 28285369
[TBL] [Abstract][Full Text] [Related]
8. Single- and multiple-dose disposition kinetics of sunitinib malate, a multitargeted receptor tyrosine kinase inhibitor: comparative plasma kinetics in non-clinical species.
Haznedar JO; Patyna S; Bello CL; Peng GW; Speed W; Yu X; Zhang Q; Sukbuntherng J; Sweeny DJ; Antonian L; Wu EY
Cancer Chemother Pharmacol; 2009 Sep; 64(4):691-706. PubMed ID: 19169880
[TBL] [Abstract][Full Text] [Related]
9. Population Pharmacokinetics of Sunitinib and its Active Metabolite SU012662 in Pediatric Patients with Gastrointestinal Stromal Tumors or Other Solid Tumors.
Wang E; DuBois SG; Wetmore C; Verschuur AC; Khosravan R
Eur J Drug Metab Pharmacokinet; 2021 May; 46(3):343-352. PubMed ID: 33852135
[TBL] [Abstract][Full Text] [Related]
10. Sunitinib-paracetamol sex-divergent pharmacokinetics and tissue distribution drug-drug interaction in mice.
Liew MH; Ng S; Chew CC; Koo TW; Chee YL; Chee EL; Modamio P; Fernández C; Mariño EL; Segarra I
Invest New Drugs; 2017 Apr; 35(2):145-157. PubMed ID: 28070719
[TBL] [Abstract][Full Text] [Related]
11. Impact of genetic variation in breast cancer resistance protein (BCRP/ABCG2) on sunitinib pharmacokinetics.
Mizuno T; Fukudo M; Terada T; Kamba T; Nakamura E; Ogawa O; Inui K; Katsura T
Drug Metab Pharmacokinet; 2012; 27(6):631-9. PubMed ID: 22673043
[TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics and hypoglycaemic effect of sunitinib in the diabetic rabbits.
Szałek E; Karbownik A; Sobańska K; Grabowski T; Połom W; Lewandowska M; Wolc A; Matuszewski M; Grześkowiak E
Pharmacol Rep; 2014 Oct; 66(5):892-6. PubMed ID: 25149997
[TBL] [Abstract][Full Text] [Related]
13. A population pharmacokinetic meta-analysis of sunitinib malate (SU11248) and its primary metabolite (SU12662) in healthy volunteers and oncology patients.
Houk BE; Bello CL; Kang D; Amantea M
Clin Cancer Res; 2009 Apr; 15(7):2497-506. PubMed ID: 19258444
[TBL] [Abstract][Full Text] [Related]
14. Effect of levofloxacin on lithium - a pharmacokinetic study in rabbits.
Rajagopalan S; Shafiq N; Pandhi P; Malhotra S
Fundam Clin Pharmacol; 2013 Apr; 27(2):181-5. PubMed ID: 22003841
[TBL] [Abstract][Full Text] [Related]
15. Sunitinib tissue distribution changes after coadministration with ketoconazole in mice.
Chee EL; Lim AY; Modamio P; Fernandez-Lastra C; Segarra I
Eur J Drug Metab Pharmacokinet; 2016 Jun; 41(3):309-19. PubMed ID: 25656737
[TBL] [Abstract][Full Text] [Related]
16. Sunitinib-ibuprofen drug interaction affects the pharmacokinetics and tissue distribution of sunitinib to brain, liver, and kidney in male and female mice differently.
Lau CL; Chan ST; Selvaratanam M; Khoo HW; Lim AY; Modamio P; Mariño EL; Segarra I
Fundam Clin Pharmacol; 2015 Aug; 29(4):404-16. PubMed ID: 26011058
[TBL] [Abstract][Full Text] [Related]
17. Integrated semi-physiological pharmacokinetic model for both sunitinib and its active metabolite SU12662.
Yu H; Steeghs N; Kloth JS; de Wit D; van Hasselt JG; van Erp NP; Beijnen JH; Schellens JH; Mathijssen RH; Huitema AD
Br J Clin Pharmacol; 2015 May; 79(5):809-19. PubMed ID: 25393890
[TBL] [Abstract][Full Text] [Related]
18. A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer.
Fountzilas G; Fragkoulidi A; Kalogera-Fountzila A; Nikolaidou M; Bobos M; Calderaro J; Andreiuolo F; Marselos M
Cancer Chemother Pharmacol; 2010 Mar; 65(4):649-60. PubMed ID: 19655144
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability and pharmacokinetic profile of levofloxacin following intravenous, intramuscular and oral administration in turkeys.
Aboubakr M; Uney K; Elmas M
Br Poult Sci; 2014 Feb; 55(1):115-9. PubMed ID: 24735473
[TBL] [Abstract][Full Text] [Related]
20. The influence of the time-of-day administration of sunitinib on the penetration through the blood-brain and blood-aqueous humour barriers in rabbits.
Sobańska K; Karbownik A; Szałek E; Płotek W; Grabowski T; Szewczyk A; Marcinkowska D; Połom W; Matuszewski M; Grześkowiak E
Eur Rev Med Pharmacol Sci; 2016; 20(1):166-73. PubMed ID: 26813470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
